chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Fatigue, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Sore Throat, Fever, Body ache, Tiredness.
Age: 29.0
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Dizziness, Dyspnoea, Headache, Nausea, Ocular hyperaemia
Clinical narrative: Onset of dizziness approximately 5 minutes after inoculation with H1N1 and seasonal flu vaccines.  2 hours following injection, throat swelling with heavy mucous production and expectoration.  3 hours, continued throat swelling accompanied by breathing difficulties at which point in time patient sought medical assistance.  Monitored. Anti-inflammatory administered orally.  5 hours following nausea (vomiting), continued mucous production and expectoration, headache, fever, red eyes.  Following day, continued headache, mucous production, fever, dark orange urine, red eyes.  Day 3, continued headache, fever broke at 2:30PM, continued orange urine production.
Age: 29.0
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Pharyngeal oedema, Productive cough, Pyrexia, Urine colour abnormal, Vomiting
Clinical narrative: Onset of dizziness approximately 5 minutes after inoculation with H1N1 and seasonal flu vaccines.  2 hours following injection, throat swelling with heavy mucous production and expectoration.  3 hours, continued throat swelling accompanied by breathing difficulties at which point in time patient sought medical assistance.  Monitored. Anti-inflammatory administered orally.  5 hours following nausea (vomiting), continued mucous production and expectoration, headache, fever, red eyes.  Following day, continued headache, mucous production, fever, dark orange urine, red eyes.  Day 3, continued headache, fever broke at 2:30PM, continued orange urine production.
Age: 59.0
Sex: M
Vaccine: HEP
Symptoms: Activated partial thromboplastin time, Blood test, Cold sweat, Electrocardiogram, Fibrin D dimer
Clinical narrative: Broke into a cold sweat. Irregular heart beat, tachycardia
Age: 59.0
Sex: M
Vaccine: HEP
Symptoms: Full blood count, Heart rate irregular, Metabolic function test, Prothrombin time, Tachycardia
Clinical narrative: Broke into a cold sweat. Irregular heart beat, tachycardia
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Balance disorder, Computerised tomogram normal, Laboratory test normal, Paraesthesia
Clinical narrative: Facial tingling left side of face  11/15/2009 to present Drowsiness and weakness 11/18/09 to  present Intermittently off balance from 5-20 times per day from 11/18/09 to present
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Somnolence
Clinical narrative: Facial tingling left side of face  11/15/2009 to present Drowsiness and weakness 11/18/09 to  present Intermittently off balance from 5-20 times per day from 11/18/09 to present
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Fall, Head injury
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Computerised tomogram abnormal, Haematemesis, Head injury, Loss of consciousness, Musculoskeletal pain
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Skull fracture, Subarachnoid haemorrhage
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Arthralgia, Balance disorder, Cerebral haemorrhage, Computerised tomogram abnormal, Dizziness
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Fall, Gait disturbance, Haematemesis, Haematocrit normal, Haemorrhage intracranial
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Head injury, Headache, Loss of consciousness, Lymphocyte count decreased, Lymphocyte percentage decreased
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Musculoskeletal pain, Neutrophil count, Neutrophil percentage increased, Pain in extremity, Red blood cell count normal
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, DTAP, HEPA, HPV4, HEPA, HPV4, TDAP
Symptoms: Skull fractured base, Subarachnoid haemorrhage, Syncope, Vomiting, White blood cell count increased
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act. A 16 year old female with left knee discomfort and left knee chondromalacia patellae on 26-AUG-2009 was vaccinated with the first dose of GARDASIL IM into the left arm (therapy dose unknown) (Lot # 662229/1497X). Concomitant therapy included the first dose of HAVRIX IM into the left arm (therapy dose unknown) (Lot # AHAVB296BA) and DTaP (unspecified) (therapy dose, site and route unknown) (manufacturer unknown). The patient sat in clinic room 10-15 minutes after administration those vaccine. The patient stated felt fine, color good and was released to check out. The patient stood 1-2 minutes and fell, possibly fainting and hitting head. The patient presented to the emergency room vomiting copious amount and with moderate amounts of bright red blood. CT revealed a subarachnoid hemorrhage and occipital skull fracture. The patient was observed overnight at the hospital and had now acute events. The patient's symptoms had now resolved except some musculoskeletal pain. On 22-SEP-2009 emergency department and medical records were received concerning the patient's status of 20-APR-2009 to 03-SEP-2009. Assessment showed skull fracture and intracranial hemorrhage secondary to vasovagal syncope. WBC 14.8 3/Ul (H), RBC 4.05 6/Ul (L), Hematocrit 34.1% (L), Seg Neut 91.5% (H) Lymph 4.6% (L), Seg Neut ABS 13.5 (H), Lymph ABS 0.7 (L). The patient presented with headache and vomiting after syncope and a fall. The patient felt light headed and lost consciousness, struck back of head on ground, occipital skull fracture, anterior intraparenchymal bleed and small subdural hemorrhage, occipital fracture, hematemeisis, pain left buttock and posterior left leg, off balance gait. Upon internal review, haemorrhage intracranial was considered to be an other important medical event. The original reporting source was not provided. The VAERS ID # is 356281. A standard lot check investigation had been finalized. All in-process quality checks for the lot number 662229/1497X in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released.
Sex: U
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Syncope, Tonic clonic movements
Clinical narrative: Syncope and collapse; brief seizure activity tonic clonic with posturing. See if resolved.
Sex: U
Vaccine: FLU(H1N1), FLU3, FLU(H1N1), FLU3
Symptoms: Full blood count, Grand mal convulsion, Laboratory test normal, Syncope
Clinical narrative: Syncope and collapse; brief seizure activity tonic clonic with posturing. See if resolved.
Age: 13.0
Sex: U
Vaccine: FLU(H1N1), FLU3, FLU3
Symptoms: Chest pain, Condition aggravated, Dizziness, Electrocardiogram abnormal, Syncope
Clinical narrative: Dizziness, fainting, chest pain self resolved
Age: 13.0
Sex: U
Vaccine: FLU(H1N1), FLU3, FLU3
Symptoms: Chest pain, Dizziness, Syncope
Clinical narrative: Dizziness, fainting, chest pain self resolved
Age: 66.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Injection site anaesthesia, Paraesthesia, Paralysis
Clinical narrative: Partial paralysis of left elbow & sensations up & down arm. My wife is totally disabled so cannot go to doctor at this time.
Age: 66.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Formication, Paralysis
Clinical narrative: Partial paralysis of left elbow & sensations up & down arm. My wife is totally disabled so cannot go to doctor at this time.
Age: 8.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1), FLUN3, FLUX(H1N1)
Symptoms: Abasia, Joint effusion, Nuclear magnetic resonance imaging abnormal, Pain in extremity, Synovitis
Clinical narrative: 2 days after administration of vaccine, leg pains for two days. Pain then affected right knee. Several days later, left knee and left hip. Experienced excruciating pain and immobility and was taken by ambulance to emergency rm. Admitted and transferred to hospitals. Right knee and right hip in addition to left. Morphine only med that alleviated pain. Did not start to recuperate until 2 1/2 weeks after initial shot.
Age: 8.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1), FLUN3, FLUX(H1N1)
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: 2 days after administration of vaccine, leg pains for two days. Pain then affected right knee. Several days later, left knee and left hip. Experienced excruciating pain and immobility and was taken by ambulance to emergency rm. Admitted and transferred to hospitals. Right knee and right hip in addition to left. Morphine only med that alleviated pain. Did not start to recuperate until 2 1/2 weeks after initial shot.
Age: 8.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1), FLUN3, FLUX(H1N1)
Symptoms: Arthralgia, Immobile, Laboratory test, Pain in extremity
Clinical narrative: 2 days after administration of vaccine, leg pains for two days. Pain then affected right knee. Several days later, left knee and left hip. Experienced excruciating pain and immobility and was taken by ambulance to emergency rm. Admitted and transferred to hospitals. Right knee and right hip in addition to left. Morphine only med that alleviated pain. Did not start to recuperate until 2 1/2 weeks after initial shot.
Age: 4.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Rash erythematous, Rash generalised
Clinical narrative: 11/20/09 at 1800 (L) deltoid immunized.  11/23/09 at 07:30 full body rash, no fever, Tx with Benadryl. 11/25/09 Rash dissipating, cheeks remain red apple like. Banana allergy: hives. Antibiotics: PCN, Amoxicillin, Augmentin.
Age: 4.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Erythema, Rash generalised
Clinical narrative: 11/20/09 at 1800 (L) deltoid immunized.  11/23/09 at 07:30 full body rash, no fever, Tx with Benadryl. 11/25/09 Rash dissipating, cheeks remain red apple like. Banana allergy: hives. Antibiotics: PCN, Amoxicillin, Augmentin.
Age: 23.0
Sex: U
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Asthenia, Blood pressure decreased, Chest pain, Cough, Dizziness
Clinical narrative: None stated
Age: 23.0
Sex: U
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: Heart rate increased, Hypoaesthesia oral, Rash, Swollen tongue, Urticaria
Clinical narrative: None stated
Age: 23.0
Sex: U
Vaccine: FLUN(H1N1), FLUN(H1N1)
Symptoms: No adverse event
Clinical narrative: None stated
Age: 9.0
Sex: F
Vaccine: HEPA, HEPA, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Skin lesion, Varicella
Clinical narrative: local reaction at injection site, diffuse rash on trunk, neck starting 12/5 (papular, some central crust), fever to 100 F 12/6 and 12/7
Age: 9.0
Sex: F
Vaccine: HEPA, HEPA, VARCEL
Symptoms: Injection site rash, Local reaction, Pyrexia
Clinical narrative: local reaction at injection site, diffuse rash on trunk, neck starting 12/5 (papular, some central crust), fever to 100 F 12/6 and 12/7
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Diarrhoea, Headache, Nausea, Pyrexia
Clinical narrative: 101 degree fever severe diarrhea mild headache/nausea
Age: 27.0
Sex: F
Vaccine: FLU(H1N1), FLUX
Symptoms: Drug exposure during pregnancy, Intra-uterine death, Uterine dilation and curettage
Clinical narrative: Pt was 18 weeks pregnant, no fetal heartbeats detected at OB/Gyn visit on Dec 2 09. IUFD, D&C done Dec 3 09
Age: 15.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Asthenia, Decreased appetite, Lethargy, Somnolence
Clinical narrative: Patient has felt weak and lethargic and had no appetite what so ever for over a week now, when she eats she feels sick. She want to sleep all the time.
Age: 25.0
Sex: M
Vaccine: FLUN3
Symptoms: Aphonia
Clinical narrative: Following the administration of the Flu Mist member states losing his voice. Vaccine received on 5Dec09 1330 and symptoms began at 1630 5Dec09.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: 11/19/09 At night at home, mom noticed about 1 inch redness and swelling, no pus or drainage. 11/21/09 Mom came back for PPD reading at clinic mom noticed increase swelling, redness, warmth, firmness. Firmness/swelling 20cm by 12cm. Doctor diagnosis cellulitis and gave Cephalexin.
Age: 16.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Headache, Pain
Clinical narrative: Severe pounding headache. Excruciating pain. Lasted several hours. Tylenol did not relieve the pain.
Age: 49.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Headache, Myalgia
Clinical narrative: Muscle soreness in arm of injection (started the day after and continues through today 12/7/2009, headache comes and goes.
Age: 36.0
Sex: M
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Grand mal convulsion
Clinical narrative: Seizure of Tonic Clonic nature with duration of approximately 2 minutes and postictal state of 2 hours.  12/07/09 ED notes received for DOS 12/05/09 and Vaccine records received for DOS 12/04/09: DX: Tonic clonic seizures   Pt presented to ED after found unresponsive. On examination: lethargic and weakness. tx: IV fluids.  Physician's impression: substance abuse.  Pt improved and discharged home.
Age: 36.0
Sex: M
Vaccine: FLU(H1N1), FLUX(H1N1)
Symptoms: Blood glucose increased, Grand mal convulsion, Postictal state
Clinical narrative: Seizure of Tonic Clonic nature with duration of approximately 2 minutes and postictal state of 2 hours.  12/07/09 ED notes received for DOS 12/05/09 and Vaccine records received for DOS 12/04/09: DX: Tonic clonic seizures   Pt presented to ED after found unresponsive. On examination: lethargic and weakness. tx: IV fluids.  Physician's impression: substance abuse.  Pt improved and discharged home.
Age: 47.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Musculoskeletal pain, Neuropathy peripheral
Clinical narrative: Brachial plexus neuropathy clinically involving the right supra spinatus nerve with right shoulder pain the day after injection and weakness 2 weeks post injection.
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Gait disturbance, Nausea, Pallor
Clinical narrative: Child c/o nausea apx 10 minutes after injection, observed pallor, unsteady gait, became weak and was assisted to the floor, RR22-24, other VSS.  Did not lose consciousness but was quite weak
Age: 54.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Diarrhoea, Vertigo, Vomiting
Clinical narrative: It was a sudden onset of diarrhea, vomiting, and vertigo (bad).  I have no idea if the shot caused it, but it lasted about an hour, and that was it. I called Medical Ctr to ask if the flu shot could have caused it, and they said it might have been possible, but they had no way to know. When I am sick from codeine, I feel much the same way, so I figured it might have been a reaction to the flu shot, but I don't know. Thought I'd report it.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Dyspnoea, Oxygen supplementation, Respiratory distress, Rhinitis, Use of accessory respiratory muscles
Clinical narrative: This 6-year old had no prior history of respiratory problems, specifically no history of asthma, croup, bronchiolitis, bronchitis or pneumonia. One day after receiving the FluMist live virus nasal influenza vaccine, the child began developing coryza. By the following day he began having difficulty breathing. By the time his mother brought him to the emergency department, 2 days after the vaccination, he was in respiratory distress. His respiratory rate was in the 50's with labored respirations, suprasternal, infracostal and rib retractions. This required emergency treatment with nebulized bronchodilators and supplemental oxygen. He was transported by critical care ambulance to hospital for admission.
Age: 8.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Asthenia, Body temperature increased, Chills, Decreased appetite, Diarrhoea
Clinical narrative: Child went to bed early (6:30 pm) awakened @ 10 pm refused food or drink. Went back to sleep. Awoke @ 2 Am with shaking, chills and multiple episodes of vomiting & diarrhea. Mother did not take temp. Reports child was weak, fell on the way to the bathroom but did not lose consciousness. Mother took to ER. T-101, child recd 2 ivs -one to believe vomiting, 1 to replace electrolytes & fluids. T came down to 98 degrees. Able to drink. Disch @ 9AM with instructions to follow up with pediatrician 11/31/09 child returned to school with MD note authorizing return.
Age: 8.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Fall, Fluid replacement, Tremor, Vomiting
Clinical narrative: Child went to bed early (6:30 pm) awakened @ 10 pm refused food or drink. Went back to sleep. Awoke @ 2 Am with shaking, chills and multiple episodes of vomiting & diarrhea. Mother did not take temp. Reports child was weak, fell on the way to the bathroom but did not lose consciousness. Mother took to ER. T-101, child recd 2 ivs -one to believe vomiting, 1 to replace electrolytes & fluids. T came down to 98 degrees. Able to drink. Disch @ 9AM with instructions to follow up with pediatrician 11/31/09 child returned to school with MD note authorizing return.
Age: 11.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Pyrexia
Clinical narrative: Grandmother states child had "very high temperature"-no exact number.
Age: 11.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Pyrexia, Vomiting
Clinical narrative: Grandmother states child woke up the day after vaccination (i.e. 11/25/09) with high temperature and vomiting. Grandmother took child to doctor.
Age: 54.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Swollen tongue, Tongue disorder
Clinical narrative: States that approx. 2 hours after receiving H1N1 vaccine she developed "little bumps" on tongue. States tongue also swollen. Denied any drainage, shortness of breath, fever, etc. States didn't eat anything unusual.
Age: 0.16
Sex: M
Vaccine: DTAPHEPBIP, PNC
Symptoms: Hypotonic-hyporesponsive episode, Vaccine positive rechallenge
Clinical narrative: Hypotonic Hyporesponsive episode with 2 and 4 month vaccines.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness
Clinical narrative: Pt left here after receiving shot- said she was in a restaurant drive through about 20 minutes later & felt like she was going to pass out-called 911 no epi administered.
Age: 9.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Pruritus, Rash
Clinical narrative: Hive like rash on neck, face, and right ear. Itching 2 days. Doctor rec. Diphenhydramine.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Oropharyngeal pain, Pharyngeal oedema, Urticaria
Clinical narrative: Developed hives on back, and sore & swollen throat.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, VARCEL
Symptoms: Cold compress therapy, Erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness, swelling and sorness at the vaccination site.  Treatment included cool packs, Claratin 10mg in the morning and bendaryl 25-50mg at bedtime.
Age: 76.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: 3:20 pt reports tingling in lips and nasal area. Pt states this is not the first time I have had this happen it happened in the past with flu and pneumonia vaccines. Pt denies chest tightness, throat irriration or wheezing. Pt is alert and oriented x3 and is up walking. Pt instructed to wait 15mins and will reassess. 3:35pm rechecked and s/s worsening. 3:37pm Benadryl 25mg po liquid given.  3:45pm pt states feeling better still some tingling. Pt instructed to continue to stay in clinic until tingling is completely resolved. 3:50pm Clinic Manager informed of patient reaction and treatment given. 3:55pm pt reports small area of tingling in center of bottom lip. 4:00pm Medical Health Officer for County Health Dept informed of patient reaction and treatment. She requested skin assessment and complete vital signs.  4:05pm upon returning to waiting room, client was not present. Per patient service representative client left building with husband at 4:00pm.
Age: 28.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Diplegia, Fatigue, Headache, Nasopharyngitis, Neck pain
Clinical narrative: Day after shot pt was very tired. Pt states that adverse symptoms began with a severe headache (11/12/09) with neck pain and weakness that lead to tingling in feet body aches and then paralysis of lower extremities on 11/21/09.  She went to a Hospital mult. times for evaluation. She admitted to another hospital on 12/3/09.  12/7/2009 ED records for multiple visits from 11/16-11/30/2009,  patient with c/o's myalgias, headache, neck pain and weakness, LP, Tx IV ABX, Decadron Toradol 12/8/2009 MR for admission 12/3/2009, patient with c/o's paresthesias and weakness of extremities, neuro exam noted loss of sensation and areflexic globally, ICU, Tx: IVIG, suspect GBS
Age: 28.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Pain, Paraesthesia
Clinical narrative: Day after shot pt was very tired. Pt states that adverse symptoms began with a severe headache (11/12/09) with neck pain and weakness that lead to tingling in feet body aches and then paralysis of lower extremities on 11/21/09.  She went to a Hospital mult. times for evaluation. She admitted to another hospital on 12/3/09.  12/7/2009 ED records for multiple visits from 11/16-11/30/2009,  patient with c/o's myalgias, headache, neck pain and weakness, LP, Tx IV ABX, Decadron Toradol 12/8/2009 MR for admission 12/3/2009, patient with c/o's paresthesias and weakness of extremities, neuro exam noted loss of sensation and areflexic globally, ICU, Tx: IVIG, suspect GBS
Age: 11.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Facial palsy
Clinical narrative: Half of face paralyzed. Diagnosed with Bells Palsy 5 days after receiving vaccine.  12/09/09 ED notes for DOS 11/24/09.  DX: Bell's palsy.  Pt c/o L facial numbness and R decreased motion, migrating aches and pain.  On examination: slight R facial droop. Neuro exam: intact sensory and motor.
Age: 60.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Body temperature increased, Pain
Clinical narrative: Received H1N1 inactivated vaccine 0.5 ml IM to Rt. deltoid at 2:10 PM.  At 6:00 PM that night developed temperature of 100.2 with body aches.  Took 2 ASA and called her doctor. By 3:00 AM felt fine.  No further symptoms.
Age: 5.0
Sex: M
Vaccine: DTAP, FLU(H1N1), IPV
Symptoms: Bursitis, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Local injection site swelling, redness, pain, itch
Age: 5.0
Sex: M
Vaccine: DTAP, FLU(H1N1), IPV
Symptoms: Local reaction, Pallor
Clinical narrative: Local injection site swelling, redness, pain, itch
Age: 7.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Epistaxis
Clinical narrative: Bloody nose (nasal mist vaccine was used); occurred during school day around mid-morning.
Age: 38.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Eye swelling, Ocular hyperaemia
Clinical narrative: Patient reports that her eyes became red and swollen about 12 hours after receiving Novel H1N1 injectable vaccine (Novartis). Patient states that her eyes remained red and swollen for 24 hours.
Age: 63.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Chest X-ray normal, Electrocardiogram normal, Facial pain, Headache, Laboratory test normal
Clinical narrative: Pt received vaccine about 8:30 am, became ill that evening with headache, malaise, "nerve" pain.  Pain in face, head, hands, and feet.  Describes shooting pain traveling down to hands and feet.  Office visit to private physician who diagnosed systemic reaction to vaccine, trigeminal nerve pain.  Physician ordered labs, ECG, Chest Xray--all reported normal.  Neurontin 300 mg BID was prescribed.  Pt reported head and "nerve" pain relieved by Neurontin.
Age: 63.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Malaise, Neuralgia, Pain, Pain in extremity, Trigeminal nerve disorder
Clinical narrative: Pt received vaccine about 8:30 am, became ill that evening with headache, malaise, "nerve" pain.  Pain in face, head, hands, and feet.  Describes shooting pain traveling down to hands and feet.  Office visit to private physician who diagnosed systemic reaction to vaccine, trigeminal nerve pain.  Physician ordered labs, ECG, Chest Xray--all reported normal.  Neurontin 300 mg BID was prescribed.  Pt reported head and "nerve" pain relieved by Neurontin.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Chills, Pain, Pyrexia
Clinical narrative: Pt developed fever,chills, and soreness. She reported to ER on 12/05/2009 and was admitted and kept overnight with a diagnosis of cellulitis. She was given IV antibiotics and sent home the next day with a prescription of Amoxicillin. She felt worse on Sunday evening when she went to another hospital. Again she was admitted with symptoms of fever and increased WBC and placed on IV rocephin and vancomycin. She is currently still an inpatient being treated.
Age: 0.81
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Pyrexia
Clinical narrative: Fever onset 6-8 hours after immunization with both H1N1 and seasonal Influenza vaccines. Fever 104-105 degrees per parents. Treated with Tylenol and Ibuprofen. Unknown if result of vaccination or other illness.
Age: 1.13
Sex: M
Vaccine: DTAP, FLU(H1N1)
Symptoms: Chest X-ray, Injection site swelling, Oxygen saturation decreased, Pyrexia, Rash papular
Clinical narrative: Developed mild papular rash over body and face x 3 wks. Some vasculitis, swelling at injection site. Mo. reported Fever 103F x 1
Age: 1.13
Sex: M
Vaccine: DTAP, FLU(H1N1)
Symptoms: Vasculitis
Clinical narrative: Developed mild papular rash over body and face x 3 wks. Some vasculitis, swelling at injection site. Mo. reported Fever 103F x 1
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site pain, Pain
Clinical narrative: Pain in R upper arm w/ movement. Unable to raise arm above shoulder without pain.
Age: 4.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Conjunctivitis, Erythema, No reaction on previous exposure to drug, Skin test, Urticaria
Clinical narrative: Pt with known egg allergy, given 1/10th dose 1st in Allergist office.  Previously tolerated full dose seasonal flu twice (recently).  Developed unilateral conjunctival inflammation erythema of left cheek, ear pinna and one hive on back.  Lungs were clear, no CNS symptoms, no cardiac symptoms.  Oxygen saturation was normal.  Given 5 mg CETIRIZINE and resolved.  Vaccine is latex free.  Office is latex free.
Age: 38.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dysphonia, Influenza serology negative, Oropharyngeal pain, Pain, Throat tightness
Clinical narrative: Body aches beginning approx, 24 hours after vaccine administration-resolved without intervention. Sore throat beginning 11/10/09 - ongoing - no treatment as yet. "Tightness" in throat beginning 11/10/09 AM-no treatment-resolved without intervention after sleeping. Hoarseness of voice beginning 11/10/09 PM, after tightness in throat resolved-ongoing- no treatment as yet.
Age: 4.0
Sex: F
Vaccine: DTAP, FLU(H1N1), FLUN3, HEPA, IPV, MMR
Symptoms: Erythema, Feeling hot, Oedema peripheral
Clinical narrative: (L) upper arm started swelling & getting red & warm area got worse as weekend progressed & area felt hot. Area measured approx. 5x5" of redness/swelling. Pt taken to ER on 11/22/09 for treatment.
Age: 44.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Balance disorder, Injection site pruritus
Clinical narrative: Itchiness at site of injection, (L) deltoid & periods of "off balance" feeling.
Age: 5.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Urticaria
Clinical narrative: <24 hours after H1N1 injection broke out in hives. They have continued intermittently for 2 weeks. Not yet resolved. Injection received at school.
Age: 62.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Insomnia, Rash pruritic, Urticaria
Clinical narrative: 1. 24hrs post vaccine - itchy rash, welts lower legs, top feet. 2. Unable to sleep- took BENADRYL - no response. 3. Cleansed area (Neutrogena) - no response. 4. 11/11/09 - Dr visit (private) - hydrocortisone cream/ BENADRYL ointment - little response. More than one week - welts/itching  encircled body, chest, back, neck 2nd visit 11/19 PERIACTIN and prednisone shot.
Age: 16.0
Sex: F
Vaccine: FLUN3, HPV4, TDAP, VARCEL
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: No adverse events to date. Patient was vaccinated with GARDASIL #1, LAIV, ADICEL, VARIVAX #2 on 10/7/09 after completing screening questionnaire that she is not pregnant. On 10/23/09 we were notified she is approximately 4 months pregnant.
Age: 16.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Syncope
Clinical narrative: Fainted.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Feeling of body temperature change, Injection site anaesthesia, Injection site pain, Oxygen saturation normal, Pain in extremity
Clinical narrative: Pain in arm at at site of injection c/o hot & cold & numbness in area VS. & O2 sat WNL.
Age: 20.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Muscular weakness
Clinical narrative: Dizziness and muscle weakness within minutes of receiving H1N1 vaccine. Was given cookies and water; rested lying down, was advised not to drive home and parents picked her up.
Age: 34.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Diarrhoea, Insomnia, Nervousness, Pain
Clinical narrative: Extreme nervousness, body aches, can't sleep. mild diarrhea.
Age: 63.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 56.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Erythema, Pain, Pruritus, Swelling, Tendonitis
Clinical narrative: Burning itching some pain redness swelling.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Electrocardiogram normal, Hyperhidrosis, Pain in extremity, Throat tightness
Clinical narrative: Pt. felt sweaty and, dizzy and shaky. Tightness in throat and pain in left arm x 15 min.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Tremor
Clinical narrative: Pt. felt sweaty and, dizzy and shaky. Tightness in throat and pain in left arm x 15 min.
Age: 19.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Alanine aminotransferase decreased, Aspartate aminotransferase normal, Rash, Rash pustular, Swelling
Clinical narrative: Within 2 weeks after the immunization she developed a progressively severe acne-type rash with swelling, pustules (infected). She was treated initially with immune system support (nutritional supplements) and then 6 weeks of tetracycline antibiotics orally, after 3 months.
Age: 55.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abdominal pain, Blood creatinine increased, Blood glucose increased, Blood potassium decreased, Blood sodium normal
Clinical narrative: Hypotension, dehydration, fever, emesis - abdominal pain on 11-23-09 late PM.  Immunization 11-23-09 in AM.  Pt. hospitalized on 11-25-09.  Seen in ER first. 12/8/2009 MR and ED records for 11/25-11/26/2009, patient with c/o's fever, abdominal pain, vomiting, lightheadedness, one incident of "passing out"
Age: 55.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Coagulation test normal, Computerised tomogram abdomen normal, Dehydration, Hypotension, Lipase normal
Clinical narrative: Hypotension, dehydration, fever, emesis - abdominal pain on 11-23-09 late PM.  Immunization 11-23-09 in AM.  Pt. hospitalized on 11-25-09.  Seen in ER first. 12/8/2009 MR and ED records for 11/25-11/26/2009, patient with c/o's fever, abdominal pain, vomiting, lightheadedness, one incident of "passing out"
Age: 55.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Liver function test normal, Pyrexia, Troponin, Vomiting
Clinical narrative: Hypotension, dehydration, fever, emesis - abdominal pain on 11-23-09 late PM.  Immunization 11-23-09 in AM.  Pt. hospitalized on 11-25-09.  Seen in ER first. 12/8/2009 MR and ED records for 11/25-11/26/2009, patient with c/o's fever, abdominal pain, vomiting, lightheadedness, one incident of "passing out"